Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New PKU mouse model developed

Sep. 25, 2018

Skeletal stem cell identified

Sep. 25, 2018

New rat model of glutaric aciduria type I confirms cerebral ammonium accumulation

Sep. 25, 2018

Repurposed antifungal may be therapy for rare blood disorder

Sep. 25, 2018

New OTC-deficient pig model of metabolic liver disease developed

Sep. 21, 2018

Hadasit Medical Research Services and Development, Ramot patent glycogen synthase inhibitors

Sep. 21, 2018

Researchers present data for GSK-773 in myopathy

Sep. 20, 2018

Encouraging results seen in CHAMPIONS study of SB-913 in mucopolysaccharidosis type II

Sep. 19, 2018

Primary and key secondary endpoints met in pivotal phase III trial of dasiglucagon

Sep. 19, 2018

CRISPR Therapeutics and ViaCyte partner on gene-edited allogeneic stem cell therapies for diabetes

Sep. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...